EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Optimization and Validation of Plasma-Based Assay for Detection and Quantification of Monoamine Neurotransmitter Metabolites Using LC–MS/MS

Lloyd Tauro, Kusuma C G, Nirpendra Singh, Vykuntaraju K Gowda, Rakesh K Mishra, Runa Hamid iD

ACS Omega · 28.07.2026 · 11 (29) · 43625-43637

DOI: 10.1021/acsomega.6c02312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 15.07.2026. Verfasst von Lloyd Tauro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tata Institute for Genetics and Society, Bengaluru 560065, India. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research, Tata Trusts.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the essential subclasses of biogenic amines is monoamine neurotransmitters, which include dopamine, serotonin, norepinephrine, and epinephrine neurotransmitters. The biosynthesis pathways of these neurotransmitters share several common substrates, metabolites, cofactors, and enzymes. Genetic mutations in these components lead to a group of rare inherited conditions termed monoamine neurotransmitter metabolic disorders (mNMDs). Existing studies report methods for measurement of a particular set of metabolites belonging to this pathway for diagnosis, frequently across different biological matrices such as cerebrospinal fluid (CSF), plasma, serum, or urine. Hence, the available assays and data are methodologically heterogeneous. In a biochemical pathway, disorder-specific metabolic patterns arise from paired alterations in multiple upstream and downstream metabolites, and these patterns can be captured only when these metabolites are measured simultaneously from the same biological matrix under similar analytical conditions. The lack of concurrent measurement limits the use of metabolite ratios, which can be of diagnostic value and pattern-based interpretation in the case of mNMDs. In this study, we report the development, optimization, and validation of a plasma-based targeted liquid chromatography–mass spectrometry (LC–MS/MS) method for the simultaneous detection and quantification of 11 key metabolites of the monoamine biosynthesis pathway. The assay was optimized for sample preparation, chromatographic separation, MS detection, and validated according to the M10 Bioanalytical Method Validation and Study Sample Analysis, US -FDA guidelines (November 2022). The method demonstrates good linearity across a broad range, high sensitivity and specificity, acceptable interday- and intraday-precision and accuracy, acceptable coefficient of variation, and lower limit of detection and quantification. The applicability of the method was further validated using plasma samples from healthy participants. As mNMDs are potentially treatable if identified early, this validated plasma-based method can provide a quick and predictive alternative to currently used different biological matrices or invasive CSF sampling for diagnosis with additional utility for longitudinal therapeutic monitoring of these treatable conditions.

Autor:innen und Institutionen

  • Tata Institute for Genetics and Society, Bengaluru 560065, India.
  • BRIC-Institute for Stem Cell Science and Regenerative Medicine, Bengaluru 560065, India.
  • Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru 560011, India.

ORCID-Profile: Runa Hamid

Förderung

  • Indian Council of Medical Research
  • Tata Trusts

Zitieren

APA

Tauro, L., C G, K., Singh, N., Gowda, V. K., Mishra, R. K., & Hamid, R. (2026). Optimization and Validation of Plasma-Based Assay for Detection and Quantification of Monoamine Neurotransmitter Metabolites Using LC–MS/MS. ACS Omega, 11(29), 43625-43637. https://doi.org/10.1021/acsomega.6c02312

Vancouver

Tauro L, C G K, Singh N, Gowda VK, Mishra RK, Hamid R. Optimization and Validation of Plasma-Based Assay for Detection and Quantification of Monoamine Neurotransmitter Metabolites Using LC–MS/MS. ACS Omega. 2026;11(29):43625-43637. doi:10.1021/acsomega.6c02312

BibTeX
@article{Tauro2026,
  author = {Tauro, Lloyd and C G, Kusuma and Singh, Nirpendra and Gowda, Vykuntaraju K and Mishra, Rakesh K and Hamid, Runa},
  title = {Optimization and Validation of Plasma-Based Assay for Detection and Quantification of Monoamine Neurotransmitter Metabolites Using LC–MS/MS},
  journal = {ACS Omega},
  year = {2026},
  volume = {11},
  number = {29},
  pages = {43625--43637},
  doi = {10.1021/acsomega.6c02312}
}
Kostenlos starten →